Arcara Jeffrey has filed 3 insider transactions across 1 company since February 2024.
Most recent transaction: a grant/award of 100000 shares of Corvus Pharmaceuticals, Inc. ($CRVS) on December 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 4, 2025 | Corvus Pharmaceuticals, Inc. | $CRVS | Arcara Jeffrey | Chief Business Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 82,836,369 | 9999.99% | 0.12% |
| Dec. 20, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | Arcara Jeffrey | Chief Business Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 66,701,086 | 9999.99% | 0.07% |
| Feb. 28, 2024 | Corvus Pharmaceuticals, Inc. | $CRVS | Arcara Jeffrey | Chief Business Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 48,025,274 | 9999.99% | 0.83% |